촉진 확산

Carrier proteins, or transporters, are embedded in the plasma membrane and enable substrates like organic compounds and ions to cross the membrane. When a substrate binds to a carrier protein, it triggers conformational changes that allow translocation without ATP expenditure. This transporter-mediated process is selective, permitting only specific molecules to bind based on structural compatibility.

Facilitated diffusion uses carrier proteins to transport solutes across the membrane, enabling faster movement than passive diffusion without a transporter. Both are passive processes requiring no ATP energy, but facilitated diffusion's use of specific transporters accelerates solute movement and provides selectivity for particular substrates based on the electrochemical gradient.

Substrate movement is governed by the electrochemical gradient, which reflects differences in concentration and charge between the inside and outside of the cell. Substrates move from areas of higher to lower electrochemical potential until equilibrium is reached, at which point concentration and charge become balanced and steady state is achieved.

Carrier protein selectivity ensures that only specific endogenous compounds or drugs can bind and be transported across the membrane. This structural specificity determines which drugs are absorbed through facilitated diffusion. For example, organic cation transporter (OCT1) selectively transports vitamins like thiamine and drugs such as metformin and levodopa, preventing non-selective transport.

When carrier proteins become saturated, all available binding sites are occupied, and the transport rate plateaus regardless of substrate concentration increases. This saturation exhibits competition kinetics, meaning drugs with similar structures compete for the same carrier proteins. Being carrier-mediated, facilitated diffusion displays these saturation and structural selectivity characteristics.

Facilitated diffusion plays a minor role in overall drug absorption because active transporters predominate in cellular uptake. However, for specific drugs that interact with selective carrier proteins like OCT1, facilitated diffusion enables intestinal absorption of vitamins and hepatic uptake of certain medications, highlighting the complexity of cellular transport mechanisms in drug administration.

When a substrate binds to a carrier protein, it induces conformational changes in the protein structure that enable the substrate to translocate across the plasma membrane. These protein shape changes are essential for moving the substrate from one side of the membrane to the other without requiring ATP energy, making facilitated diffusion an efficient passive transport mechanism.